Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation
Clinical trials sponsored by Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation, explained in plain language.
-
New antibody drug targets COVID-19 early
Disease control Not yet recruitingThis early-stage study tests a new drug called B10-FC, made from human antibodies, to treat COVID-19 soon after infection. It involves 35 healthy volunteers and COVID-19 patients to check safety and how the body processes the drug. The goal is to see if it can help control the vi…
Phase: PHASE1 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New drug tested in healthy people to check safety first
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug, Fluorothiazinone, in 70 healthy adults aged 18 to 45. The goal is to see if it is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor for side effects. This study does not aim to t…
Phase: PHASE1 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC